It was previously reported that two oligonucleotide primer sets (spn9802 and spn9828) for discriminating Streptococcus pneumoniae from pneumococcus-like oral streptococcal isolates using PCR had been developed. In this study, PCR amplification of the lytA, ply, spn9802 and spn9828 genes was used to identify presumptive S. pneumoniae. Two genetic groups were identified by analysing sputum samples from 28 patients with community-acquired pneumonia: the lytA-positive, ply-positive, spn9802-positive and spn9828-negative group, and the lytA-positive, ply-positive, spn9802-positive and spn9828-positive group. Isolates of the former group were resistant to optochin, while those of the latter group showed susceptibility to optochin. The lytA-positive, ply-positive, spn9802-negative and spn9828-negative isolates, and lytA-positive, ply-positive, spn9802-negative and spn9828-positive isolates, were not detected in sputum from patients with pneumonia. Subsequently, a total of 92 saliva samples from healthy individuals was screened by PCR using these primer sets. The lytA-positive, ply-positive, spn9802-positive and spn9828-negative group was identified more frequently in saliva from healthy children than in saliva from older healthy individuals and patients with pneumonia. The lytA-positive, ply-positive, spn9802-positive and spn9828-positive group was found frequently in saliva from healthy children, and in saliva and sputum from patients with pneumonia. This study demonstrates a rapid, optimal screening method for the genotypic identification of presumptive S. pneumoniae by PCR using four genes highly specific for S. pneumoniae.
INTRODUCTION
Streptococcus pneumoniae (the pneumococcus) is a common major human pathogen associated with community-acquired pneumonia, septicaemia, meningitis and otitis media (Brown & Lerner, 1998) . Recently, various molecular assays, including a DNA probe test (Davis & Fuller, 1991; Denys & Carey, 1992) , a loop-mediated isothermal amplification method (Seki et al., 2005) , and a TaqMan real-time PCR assay (Corless et al., 2001) , in addition to conventional PCR, have been developed and employed to identify pneumococcal strains and to detect pneumococci directly in clinical samples. PCR-based assays for identifying S. pneumoniae have frequently targeted genes encoding pneumococcal virulence factors, including autolysin (McAvin et al., 2001) , pneumolysin (Corless et al., 2001) , pneumococcal surface antigen A (Morrison et al., 2000) , manganese-dependent superoxide dismutase (Kawamura et al., 1999) , and penicillin-binding protein (O'Neill et al., 1999) . The autolysin (lytA) and pneumolysin (ply) genes have been used for screening S. pneumoniae (Gillespie et al., 1994; Ubukata et al., 1996) . Ideally, the amplification of these target genes should be specific for S. pneumoniae isolates only. However, the application of this strategy is complicated by recent reports that organisms that are genotypically and phenotypically related to oral streptococci, notably Streptococcus mitis and Streptococcus oralis, harbour the genes encoding the S. pneumoniae virulence factors autolysin and pneumolysin (Seki et al., 2005; Verhelst et al., 2003; Whatmore et al., 2000) .
In a previous study, we developed two primer sets, spn9802 and spn9828, that were highly specific for S. pneumoniae, in order to discriminate S. pneumoniae from pneumococcuslike oral streptococci harbouring the lytA and ply genes, by genomic subtractive hybridization between S. pneumoniae WU2 and S. mitis 903 (Suzuki et al., 2005) . The ORFs of S. pneumoniae R6 (GenBank accession no. AE007317) corresponding to the spn9802 and spn9828 amplicons encode proteins of unknown function and show no marked homology with those of any organisms other than S. pneumoniae. The ORF of S. pneumoniae R6 corresponding to spn9802 has not been deposited in the GenBank database, while the gene of spn9828 corresponds to spr1523 identified by Hoskins et al. (2001) . In this study, we tested the applicability of PCR amplification of four different genes, lytA, ply, spn9802 and spn9828, for identifying S. pneumoniae in 28 sputum samples from patients with pneumonia, and we classified the strains harbouring these pneumococcal genes into two genotypes. Subsequently, we examined the distribution of the genotypes in the saliva of healthy Japanese individuals. We found that PCR amplification with spn9802-and spn9828-specific primers, in combination with lytA-and ply-specific primers, was useful for identifying the genotypes of presumptive S. pneumoniae.
METHODS
Study population. To estimate infection of the oral cavity with S. pneumoniae and other pneumococcus-like alpha-haemolytic streptococci in Japanese individuals, a total of 92 saliva samples from healthy subjects, including 30 preschool children (mean age 4?1± 0?9 years, range 3-6 years), 32 young adults (mean age 29?9±7?2 years, range 22-50 years) and 30 older people (mean age 69?5±5?36 years, range 62-79 years), and 20 saliva and 28 sputum samples from patients with community-acquired pneumonia (mean age 67?3± 18?3 years, range 29-92 years) were examined by PCR using lytA-, ply-, spn9802-and spn9828-specific primers. All subjects and parents of preschool children who participated in this study understood the nature of the research project and gave informed consent.
Bacterial isolation and identification. All sputum samples were homogenized with 2 % (w/v) N-acetyl-cysteine (Mucofilin; Eisai) and inoculated onto 5 % (v/v) blood agar (Becton Dickinson) and 5 % (v/v) heated blood agar (Becton Dickinson). Both plates were incubated at 37 uC in an atmosphere of 5 % CO 2 . To distinguish between S. pneumoniae and other alpha-haemolytic streptococci, the optochin-susceptibility test was performed using a 6?5 mm diameter disc containing 5 mg optochin (Eiken Chemical) in an atmosphere of 5 % CO 2 . The absence of an inhibition zone of at least 13 mm diameter was interpreted as a negative result, whereas a zone of inhibition of at least 13 mm diameter constituted a positive result.
Primer design. The oligonucleotide sequences of PCR primers used in this study are listed in Table 1 . The oligonucleotide primers for the lytA and ply genes were designed as previously described by Nagai et al. (2001) and Salo et al. (1995) , respectively. We have previously used genomic subtractive hybridization to develop S. pneumoniae-specific spn9802 and spn9828 primers for discriminating pneumococci from other pneumococcus-like oral streptococci (Suzuki et al., 2005) .
Preparation of template DNA for PCR assay. Saliva and sputum samples were prepared for PCR amplification as follows. Briefly, 500 ml saliva and the same amount of PBS (0?12 M NaCl, 0?01 M Na 2 HPO 4 , 5 mM KH 2 PO 4 , pH 7?5) were mixed and centrifuged at 12 000 g for 10 min. Sputum and viscous saliva were mixed with 1 ml PBS using a vortexer for at least 30 s, and 500 ml supernatant was centrifuged at 12 000 g for 10 min. Then, 250 ml cell lysis buffer (1 % Triton X-100, 20 mM Tris/HCl, 2 mM EDTA, pH 8?0) was added to the pellet, and the bacterial chromosomal DNA was extracted by boiling at 100 uC for 10 min. After the lysed cells were centrifuged, the supernatant containing the bacterial DNA was removed and frozen at 230 uC until use.
PCR assay. Amplification reactions were conducted using a TaKaRa PCR Thermal Cycler (TaKaRa Bio) with the following temperature profile: initial denaturation at 94 uC for 2 min, then 25 cycles consisting of 94 uC for 10 s, 58 uC for 15 s, and 72 uC for 1 min, followed by a final extension step at 72 uC for 5 min. The amplification products were loaded onto 1?8 % (w/v) agarose gels, separated by electrophoresis, stained with ethidium bromide (0?5 ml ml 21 ), and photographed under UV light.
Statistical analysis. The statistical analysis of the difference in the frequency of the pneumococcal genes among clinical specimens was performed using the chi square and Fisher's probability tests.
RESULTS AND DISCUSSION

Relationship between genetic type and optochin susceptibility
Optochin susceptibility is the phenotypic characteristic most frequently used to differentiate between S. pneumoniae and other alpha-haemolytic streptococci. However, optochinresistant S. pneumoniae strains and optochin-sensitive oral streptococci are being isolated more frequently (Pikis et al., 2001; Whatmore et al., 2000) , and may therefore be overlooked or misidentified, respectively, as many clinical microbiology laboratories today depend on the optochinsusceptibility test (Chandler et al., 2000) . In the present study, the optochin-susceptibility test, and PCR amplification of the pneumococcal genes encoding the putative virulence factors autolysin (lytA) and pneumolysin (ply) and the highly specific pneumococcal genes spn9802 and spn9828, were performed on sputum samples from 28 patients with community-acquired pneumonia. Table 2 shows the distribution of pneumococcal genes in 15 sputum samples amplified with all primers by PCR. Ten specimens (35?7 %) gave amplification with both the lytA-and plyspecific primers, which encode typical pneumococcal virulence factors, and were classified into two genetic types: the lytA-positive, ply-positive, spn9802-positive and spn9828-positive genetic type, and the lytA-positive, ply-positive, spn9802-positive and spn9828-negative genetic type. Optochin-sensitive strains were isolated from samples positive for all four primer sets. One of them was identified as penicillin-resistant S. pneumoniae (patient 2). These isolates were typical S. pneumoniae in both the genotype and phenotype analyses. The clinical isolates from the lytApositive, ply-positive, spn9802-positive and spn9828-negative samples showed resistance to optochin. Therefore, these isolates were identified as pneumococci by the genotype analysis, but would be considered to be other alphahaemolytic streptococci by the optochin-susceptibility test. In a previous study, four pneumococcal isolates and 20 pneumococcus-like oral streptococcal isolates were tested to evaluate spn9802-and spn9828-specific primers (Suzuki et al., 2005) . All four pneumococcal isolates were positive with the lytA-, ply-, spn9802-and spn9828-specific primers and sensitive to optochin, while all 20 pneumococcus-like oral streptococcal isolates were resistant to optochin. It would be of interest to study whether the organisms of the genetic type that are positive with the lytA-, ply-, and spn9802-specific primers are optochin-resistant S. pneumoniae or another alpha-haemolytic streptococcus harbouring three pneumococcal genes. It would also be of interest to investigate the difference in virulence and pathology between the two genetic types. The lytA-positive, ply-positive, spn9802-negative and spn9828-negative genetic type, and the lytApositive, ply-positive, spn9802-negative and spn9828-positive genetic type were not identified. The other five specimens containing pneumococcal genes showed various amplification patterns, and their isolates were resistant to optochin.
Genetic analysis for healthy individuals and patients with pneumonia
Subsequently, a total of 92 saliva samples from healthy individuals were examined by PCR using the lytA-, ply-, spn9802-and spn9828-specific primers, and compared with the results of saliva and sputum samples from the same 20 patients with community-acquired pneumonia (Table 3 ). The frequency of the ply gene was significantly higher than that of the other genes specific for S. pneumoniae at P<0?0001 in saliva from healthy individuals and P<0?05 in saliva and sputum from patients with pneumonia. There was a significant difference between the frequency of lytA and spn9802 or spn9828 in saliva from healthy individuals (P<0?01), while there was no significant difference in saliva and sputum from patients from pneumonia. Furthermore, the spn9802 gene was detected frequently in saliva from healthy children and sputum from patients with pneumonia (P<0?05), while the spn9828 gene was detected more frequently in sputum from patients with pneumonia than that from healthy patients. This suggests that many oral bacteria harbouring lytA or ply genes inhabit the human oral cavity, and that the spn9802 and spn9828 genes are highly specific for S. pneumoniae.
Both lytA-and ply-positive specimens were detected significantly more often in saliva from children than in saliva from young people (P<0?01) or from patients with pneumonia (P<0?05; Table 4 ). This genotypic pattern, harbouring both genes that encode putative essential pneumococcal virulence factors, is used for the presumptive identification of S. pneumoniae. The mean age of patients with pneumonia tested in this study was 65 years (range 29-92 years). These findings suggest that the distribution of S. pneumoniae has not been increasing rapidly in patients with community-acquired penumonia.
Next, we classified the specimens harbouring both the lytA and ply genes into three genetic types, using the results of the amplification with the spn9802-and spn9828-specific primers in addition to the lytA-and ply-specific primers (Table 4) . Interestingly, no lytA-positive, ply-positive, spn9802-negative and spn9828-negative specimens were detected in any saliva or sputum samples from patients with pneumonia. In contrast, lytA-positive, ply-positive, spn9802-positive and spn9828-positive specimens, which represent the most typical pneumococcal genotype, were identified frequently in saliva and sputum from patients with pneumonia; lytA-positive, ply-positive, spn9802-positive and spn9828-negative specimens were identified more frequently in saliva from healthy children than in saliva from older healthy individuals or patients with pneumonia (P<0?05). Although the functional analysis of the proteins encoded by spn9802 and spn9828 has not been performed, their association with the virulence of S. pneumoniae has been suggested.
Assessment of the PCR amplification of four pneumococcal genes
The analysis of sputum from patients with communityacquired pneumonia suggests that the lytA primers are the all-powerful primers for detecting S. pneumoniae (Table 2) . The lytA gene has been frequently used as a reliable target for the identification of S. pneumoniae (Gillespie et al., 1994; Kawamura et al., 1999; Ubukata et al., 1996) , and it has been reported that the lytA gene has higher specificity than the ply gene for S. pneumoniae (Neeleman et al., 2004) . Recently, however, the existence of organisms that appear to be genotypically and phenotypically related to S. mitis, but which harbour the lytA gene normally associated with pneumococci, has been reported (Seki et al., 2005) . We detected six saliva samples from healthy young adults (18?7 %) and one saliva sample from a healthy child (3?33 %) that harboured only the lytA gene (data not shown). Saliva samples from 26?6 % of healthy children, 25 % of healthy young adults, 36?6 % of healthy older people, and 25 % of patients with pneumonia, as well as 10 % of sputum samples from patients with pneumonia, were amplified using only the ply primers (data not shown). Since the spn9802 and spn9828 primer sets amplified a few chromosomal DNA extracts from sputum samples from which S. pneumoniae was not isolated, they are not yet regarded as complete primer sets for the detection of S. pneumoniae (Table 2) . Amplification by both the lytA-and ply-specific primers was detected in 56?6 % of saliva samples from healthy children and in 45 % of sputum samples from patients with community-acquired pneumonia. The frequencies were consistent with those of genes from the teeth and tongue of young children detected by DNA-DNA checkerboard with digoxigenin-labelled, whole-chromosomal DNA probes for S. pneumoniae (Tanner et al., 2002 ). An identification assay using DNA probes has been reported to show 100 % specificity and sensitivity for pneumococci (Davis & Fuller, 1991; Denys & Carey, 1992) , but is prohibitively expensive for routine diagnostic use. PCR techniques using the lytA and ply genes may be adequate to screen for presumptive S. pneumoniae and may reduce costs; however, nonpneumococcal species harbouring both lytA and ply genes have been identified (Whatmore et al., 2000) . The lytApositive, ply-positive, spn9802-negative and spn9828-negative specimens were detected in 17 saliva samples from 92 healthy individuals (18?4 %), but were not detected in saliva or sputum from patients with community-acquired pneumonia. In contrast, lytA-positive, ply-positive, spn9802-positive and spn9828-negative specimens, and specimens positive for all four primer sets were frequently detected in healthy children and in patients with pneumonia. The risk groups for pneumococcal infection are young children, older people and immune-deficient patients. The genetic analysis of clinical samples, including PCR of saliva and sputum using these four primer sets, will be useful in screening for S. pneumoniae and other alpha-haemolytic streptococci, and will contribute to the study of the pathology and classification of these organisms.
